Steven Kelly - Jan 31, 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
President and CEO, Director
Signature
/s/ Richard Morris, as Attorney-in-Fact for Steven Kelly
Stock symbol
CARM
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 04:52 PM
Previous filing
Aug 8, 2023
Next filing
Mar 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +438K $0.00 438K Jan 31, 2024 Common Stock 438K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.